New registry tracks YORVIPATH in pregnancy to assess safety for mom and baby
NCT ID NCT07345494
First seen Jan 19, 2026 · Last updated May 25, 2026 · Updated 13 times
Summary
This study is a pregnancy registry that collects information from women who took YORVIPATH for hypoparathyroidism around the time of pregnancy or while breastfeeding. Researchers will follow about 50 women and their babies for at least a year to watch for complications, birth defects, and developmental milestones. The goal is to better understand the risks and safety of this medication during pregnancy and breastfeeding.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOPARATHYROIDISM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ascendis Investigational Site
RECRUITINGMorgantown, West Virginia, 26508, United States
Conditions
Explore the condition pages connected to this study.